drugset / Trial / NCT03083158
Immunity to Hepatitis B Vaccine
Phase 4
Completed
16 enrolled
University of British Columbia
Human Vaccines Project · collabInstitut Pasteur · collabJ. Craig Venter Institute · collabThe Scripps Research Institute · collabUniversity of California, San Diego · collabVanderbilt University · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
Infection and cancer is a major cause of death and morbidity, and may be preventable through vaccination. It is not fully understood at the molecular level why some people respond better than others to vaccines until now the technology to assess this has not been available. This has impaired vaccine development. The overall goal of the Human Vaccines Project is to understand the 'rules' of how vaccines work. In this demonstration project the investigators will vaccinate healthy adults with hepatitis B vaccine to start to understand better how it works, ultimately helping with rational vaccine design in the future.
Timeline
- Start
- 2017-03-06
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | 20 ug | Intramuscular |
| Subject | Hepatitis B vaccine | Vaccine | 1 ml | Intramuscular |